TCL Archive IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies May 8, 1987
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive In Brief: Lou Carrese, NCI Associate Director, Dies; Myers, Ransahoff Head Two New Organ Systems Group May 9, 1986
